As there are no systematic studies of ALYREF and its role in human breast cancer, we aimed for the first time to explore and comprehensively characterize the putative role of this RNA-binding protein and transcriptional activator in human breast carcinogenesis. This evidence concerns the gene ALYREF and breast carcinoma.